Cargando…
Direct comparison of circulating tumor DNA sequencing assays with targeted large gene panels
Next generation sequencing (NGS) assays with large targeted gene panels can comprehensively profile cancer somatic mutations in a tumor sample. Given the rapid adoption of such assays for circulating tumor DNA (ctDNA) analysis in clinical oncology, it is essential for the community to understand the...
Autores principales: | Yu, Lizhi, Lopez, Gonzalo, Rassa, John, Wang, Yixin, Basavanhally, Tara, Browne, Andrew, Huang, Chang-Pin, Dorsey, Lauren, Jen, Jin, Hersey, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049497/ https://www.ncbi.nlm.nih.gov/pubmed/35482763 http://dx.doi.org/10.1371/journal.pone.0266889 |
Ejemplares similares
-
Autoimmune gene expression profiling of fingerstick whole blood in Chronic Fatigue Syndrome
por: Wang, Zheng, et al.
Publicado: (2022) -
Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors
por: Imai, Mitsuho, et al.
Publicado: (2022) -
Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft‐tissue sarcomas
por: Blanchi, Julie, et al.
Publicado: (2023) -
A Targeted Gene Panel for Circulating Tumor DNA Sequencing in Neuroblastoma
por: Cimmino, Flora, et al.
Publicado: (2020) -
A large-scale dataset of in vivo pharmacology assay results
por: Hunter, Fiona M. I., et al.
Publicado: (2018)